• Claus Zippel and Sabine Bohnet-Joschko.
• Walcker Endowed Professor of Management and Innovation in Health Care, Faculty of Management and Economics, Witten/Herdecke University, Alfred-Herrhausen-Straße 50, 58448 Witten, Germany. Electronic address: Claus.Zippel@uni-wh.de.
• Health Policy. 2017 Aug 1; 121 (8): 880-886.

AbstractMedical devices play a central role in the diagnosis and treatment of diseases but also bring the potential for adverse events, hazards or malfunction with serious consequences for patients and users. Medical device manufacturers are therefore required by law to monitor the performance of medical devices that have been approved by the competent authorities (post market surveillance). Conducting a nationwide online-survey in the German medical device sector in Q2/2014 in order to explore the current status of the use of post market instruments we obtained a total of 118 complete data sets, for a return rate of 36%. The survey included manufacturers of different sizes, producing medical devices of all risk classes. The post market instruments most frequently reported covered the fields of production monitoring and quality management as well as literature observation, regulatory vigilance systems, customer knowledge management and market observation while Post Market Clinical Follow-up and health services research were being used less for product monitoring. We found significant differences between the different risk classes of medical devices produced and the intensity of use of post market instruments. Differences between company size and the intensity of instruments used were hardly detected. Results may well contribute to the development of device monitoring which is a crucial element of the policy and regulatory system to identify device-related safety issues.Copyright © 2017 Elsevier B.V. All rights reserved.

13 keywords...

hide…